Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist
Aleix Cases;
Nefrologia (English Version). 2023;43:399-412
Clinical Practice Guideline for detection and management of diabetic kidney disease: A consensus report by the Spanish Society of Nephrology
Nuria Montero; Laia Oliveras; Alberto Martínez-Castelao; José Luis Gorriz; María José Soler; Beatriz Fernández-Fernández; Maria Quero; Clara García-Carro; Paula Garcia-Sancho; Marian Goicoechea; Juan Jose Gorgojo Martínez; Pablo Molina; María Jesús Puchades; Diana Rodríguez-Espinosa; Nery Sablón; Rafael Santamaría; Juan Francisco Navarro-González;
Nefrologia (English Version). 2025;45 Supl 1:1-26
Hypertension mediated kidney and cardiovascular damage and risk stratification: Redefining concepts
Diego Francisco Márquez; Elena Rodríguez-Sánchez; Julián Segura de la Morena; Luis Miguel Ruilope; Gema Ruiz-Hurtado;
Nefrologia (English Version). 2022;42:519-30